AU4130597A - Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes - Google Patents

Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes

Info

Publication number
AU4130597A
AU4130597A AU41305/97A AU4130597A AU4130597A AU 4130597 A AU4130597 A AU 4130597A AU 41305/97 A AU41305/97 A AU 41305/97A AU 4130597 A AU4130597 A AU 4130597A AU 4130597 A AU4130597 A AU 4130597A
Authority
AU
Australia
Prior art keywords
erythrocytes
prevention
treatment
fatty acids
essential fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41305/97A
Other languages
English (en)
Inventor
David Frederick Horrobin
Catherine Ann Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Publication of AU4130597A publication Critical patent/AU4130597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU41305/97A 1996-10-14 1997-09-11 Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes Abandoned AU4130597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9621373.1A GB9621373D0 (en) 1996-10-14 1996-10-14 Fatty acid treatment
GB9621373 1996-10-14
PCT/GB1997/002441 WO1998016215A1 (fr) 1996-10-14 1997-09-11 Utilisation d'acides gras essentiels pour le traitement et la prevention de dommages par rayonnement aux erythrocytes

Publications (1)

Publication Number Publication Date
AU4130597A true AU4130597A (en) 1998-05-11

Family

ID=10801378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41305/97A Abandoned AU4130597A (en) 1996-10-14 1997-09-11 Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes

Country Status (4)

Country Link
AU (1) AU4130597A (fr)
GB (1) GB9621373D0 (fr)
WO (1) WO1998016215A1 (fr)
ZA (1) ZA978226B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003514855A (ja) * 1999-10-13 2003-04-22 チャコン，マルコ，エー． カロリー制限の効果を模倣した治療的介入
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
US8092839B2 (en) 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8431165B2 (en) 2004-12-13 2013-04-30 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
CN103052704A (zh) 2010-07-22 2013-04-17 荷兰联合利华有限公司 用于提高清洁的鼠李糖脂和酶的组合物
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
KR102391827B1 (ko) 2014-06-04 2022-04-27 디에스 바이오파마 리미티드 Dgla를 포함하는 약제학적 조성물 및 그의 용도
CN108741081A (zh) * 2018-06-29 2018-11-06 许昌元化生物科技有限公司 一种含有亚麻酸的复合微粉及其制备方法
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58180423A (ja) * 1982-04-16 1983-10-21 Nippon Suisan Kaisha Ltd 末梢血流障害治療剤
GB8920228D0 (en) * 1989-09-07 1989-10-18 Efamol Holdings Fatty acid therapy
GB9301446D0 (en) * 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage

Also Published As

Publication number Publication date
WO1998016215A1 (fr) 1998-04-23
GB9621373D0 (en) 1996-12-04
ZA978226B (en) 1998-05-11

Similar Documents

Publication Publication Date Title
AU4124997A (en) Fatty acid treatment
AU7734391A (en) Essential fatty acid treatment
AU4081489A (en) Fatty acid therapy and compositions
PL331861A1 (en) Derivatives of propionic acid and their application
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU2159092A (en) Use of lysophosphate acids for the treatment of skin wrinkles
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
AU3410195A (en) Method of inhibiting tissue ischemia and reperfusion injury
AU1642395A (en) Alpha-aminoalkanoic acids and reduction products
AU659456B2 (en) Fatty acid treatment
AU3236093A (en) The use of ob-101 to treat inflammation
AU2626895A (en) Production and uses of caffeic acid and derivatives thereof
AU4130597A (en) Use of essential fatty acids for the treatment and prevention of radiation damage to erythrocytes
AU1438295A (en) Method for treatment of papulo-pustules and comedones of the skin
AU2821295A (en) Compositions and methods for the treatment of tumors
AU8588898A (en) Composition and process for the treatment of epidermal traumas such as decubitusulcers
AU3235693A (en) The use of ob-104 to treat inflammation
AU1571995A (en) Method for processing semi-liquid manure and the device to be used
AU2969597A (en) Treatment of vascular lesions
AU1596497A (en) Skin treatment with salicylic acid esters
AU3176595A (en) Fatty acid treatment
AU3192795A (en) Use of quinone and hydroquinone derivatives for the teatment of cachexia
HK1002256A1 (en) Phenylalkanoic acid esters and their use as antioxidants
AU4678893A (en) Compositions and methods for topical treatment of skin lesions
AU2115197A (en) Compositions and methods useful in the detection and/or treatment of cancerous conditions